H.R. 5202
Reported by CommitteeEnsuring Patient Access to Substance Use Disorder Treatments Act of 2018
Latest Action
Ordered to be Reported by Voice Vote.
5/9/2018 • House
Summary
Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018
This bill amends the Controlled Substances Act to allow a pharmacy to deliver a controlled substance to a practitioner, in accordance with a prescription, to be administered to a specific patient for maintenance or detoxification treatment or through an intrathecal pump.
The bill directs the Government Accountability Office to report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.
Introduced in House • 3/7/2018
Topics & Subjects
CBO Cost Estimates (1)
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (8)
Party Breakdown
Sponsor
Cosponsors (7)
Bill Journey
Originated in the House
Introduced
March 7, 2018
Committee Review
April 25, 2018
Forwarded by Subcommittee to Full Committee by Voice Vote .
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law